Finesse Solutions announces the opening
of a new office in Shanghai, China.

Santa Clara, CA (January 15, 2015)

Finesse Solutions has opened a subsidiary office in Shanghai to serve the active Chinese market. Centrally located in the Huangpu District, the office overlooks the lovely Taipingquiao Park.

Specifically designed to serve the needs of both current and prospective customers, the facility will provide offices for sales and service personnel, the ability to stock a significant parts inventory, and a training center.

Dr. Barbara Paldus, CEO of Finesse Solutions, is excited about the new office. “Over the course of the last year, Finesse has significantly expanded its business in China. We are pleased to announce that our new sales and service center in Shanghai will allow us to provide our customers with local support and training.”

Shanghai is considered a strategic hub in the Asian market, as it is located near major areas of biotech expansion like Seoul, Tokyo, and Singapore. The new facility will enable Finesse staff to assist customers in this region and more quickly help them in finding solutions to processing challenges. 

The Finesse portfolio of control, automation and single-use solutions continues to expand with new products ranging from single-use 3L SmartVessels for R&D to its new SmartFactory enterprise solution. The Finesse team in Shanghai is looking forward to helping customers significantly enhance the development of new health-care solutions.

About Finesse Solutions, Inc.

Finesse Solutions provides flexible hardware and software automation which allows for unmatched customizable bioprocessing. We are a research based, Silicon Valley company who believes in empowering our clients with innovative single-use sensors, bioreactors, controllers and software.  Our SmartParts are the foundation of a Finesse solution using technologies from inside and outside of the biopharmaceutical industry. In addition to our own products, we are the only supplier with integration expertise offering clients the independence to select any preferred supplier of key unit operations from upstream to downstream. Whether it’s a stand-alone, single-use bioreactor for research and development or a fully integrated Smartfactory in cGMP manufacturing, we have a bioprocess solution for our customers. For more information, please visit us at www.finesse.com.

Media: Barbara Paldus, 408 570 9012